Hypertensive nephropathy: Difference between revisions
No edit summary |
|||
| Line 34: | Line 34: | ||
==Treatment== | ==Treatment== | ||
[[Hypertensive nephropathy medical therapy|Medical Therapy | [[Hypertensive nephropathy medical therapy|Medical Therapy]] | [[Hypertensive nephropathy primary prevention|Primary Prevention]] | [[Hypertensive nephropathy secondary prevention|Secondary Prevention]] | [[Hypertensive nephropathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hypertensive nephropathy future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Revision as of 15:37, 27 September 2012
Template:DiseaseDisorder infobox For patient information, click here
|
Hypertensive nephropathy Microchapters |
|
Differentiating Hypertensive Nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertensive nephropathy On the Web |
|
American Roentgen Ray Society Images of Hypertensive nephropathy |
|
Risk calculators and risk factors for Hypertensive nephropathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Synonyms and keywords: Hypertensive nephrosclerosis
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Hypertensive nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies